Deep cerebellar nucleus stimulation for refractory tremor

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 1 study implants the Medtronic Percept RC deep brain stimulation system to target the deep cerebellar nuclei in adults with refractory tremor. Eligible participants have essential tremor, cerebellar outflow tremor, or MS-related tremor and either failed prior VIM DBS or HIFU thalamotomy or are not considered suitable candidates for those procedures. The primary objective is to document safety and feasibility by tracking surgical and device-related adverse events and clinical response after implantation and programming. The single-center trial is conducted at the Cleveland Clinic and will include follow-up visits to monitor tremor severity and functional status.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 21 years and older;
* Ability to give informed consent;
* Diagnosis of ET, cerebellar tremor, or MS-related tremor with a failed a prior intervention (VIM DBS or HIFU thalamotomy) or determined to not be suitable candidates for VIM DBS or HIFU thalamotomy because they have a cerebellar outflow or MS-related tremor.
* Tremor history of at least three years;
* Tremor that is refractory to medical management;
* A score of ≥24 on the Mini Mental State Examination;
* Inability to successfully perform ADLs without assistance or has lost interest in social, professional, or personal activities due to tremor

Exclusion Criteria:

* Any other neurological condition that could reduce the safety of study participation including central nervous system vasculitis and intracranial malignancy
* A condition that, in the opinion of the clinical investigator, would significantly increase the risk or interfere with study compliance, safety, or outcome;
* A diagnosis of dementia;
* Tremors due to other neurological conditions such as Parkinson's disease, dystonia, or other conditions not consistent with ET, cerebellar outflow tremor, or MS-related tremor.
* Diagnosis of epilepsy;
* Major active and untreated psychiatric illness that may interfere with study, such as psychotic disorders or severe personality disorders;
* Untreated or inadequately treated depression defined by a score of 20 or greater on the Beck Depression Inventory-II at the time of enrollment;
* At risk for suicide defined by a score greater or equal to 3 on the Columbia Suicide Severity Rating Scale (C-SSRS);
* Pregnancy;
* Unable to communicate with investigators or staff;
* Surgical contraindications to DN DBS;
* Contraindication to magnetic resonance (MRI) imaging, e.g., weight incompatible with scanner, implanted metallic devices or electrical devices (pacemaker, defibrillator, spinal cord stimulator, prior DBS) or intolerance to MRI contrast agent;
* Enrolled in another device, biologic or pharmaceutical study within 30 days of consent in the current study, (i.e., patient cannot be enrolled if participation in another study was not completed at least 30 days prior to consent.);
* Evidence of behavior(s) consistent with alcohol or substance abuse/dependence as defined by the criteria outlined in the DSM-V within the preceding six months;
* Injection of botulinum toxins into the arm, neck or face within six months prior to baseline;

Where it's running

• Cleveland Clinic
  Cleveland, Ohio, United States Recruiting

Study contacts

• Study coordinator: Jeffrey Negrey, MA
• Email: negreyj2@ccf.org
• Phone: 2163166896

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-term evaluation of Abbott deep brain stimulation systems for movement disorders

  This study is testing how safe and effective Abbott deep brain stimulation systems are for people with movement disorders like Parkinson's disease over a five-year period.

  Recruiting at 24 sites Abbott Medical Devices · Tucson, Arizona and 47 other locations · NCT04071847

• Using stereotactic radiosurgery to treat essential and Parkinsonian tremors

  This study is testing if a new type of radiation treatment can help people with essential tremor or Parkinsonian tremor feel better and improve their quality of life.

  Recruiting Vanderbilt University Medical Center · Nashville, Tennessee · NCT01734122

• Encora X1 in Daily Life for Essential Tremor

  This real-world study tests how the Encora X1 wrist device affects day-to-day activities for adults with essential tremor over three years.

  Recruiting Encora, Inc. · Boston, Massachusetts · NCT07911488

• Intraoperative Microelectrode Recordings with MAVEN vs Standard Equipment

  This study tests whether MAVEN can match the recording data collected during DBS surgery for movement disorders using standard equipment.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07868614

• Microelectrode-based brain stimulation for Parkinson’s and essential tremor

  This early feasibility test checks a new microelectrode-based brain stimulation method in adults with Parkinson’s disease or essential tremor who are already getting deep brain stimulation implants.

  Recruiting Lund University · Lund, Skåne County · NCT07820189

• Non-Invasive Nerve Stimulation for Essential Tremor: Long-Term Safety and Effectiveness

  This study tests whether a non-invasive stimulation device called TAPS helps reduce tremor in adults with essential tremor over a long period.

  Recruiting Ruijin Hospital · Shanghai · NCT07774598

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.